Abstract Objectives Pneumococcal conjugate vaccines (PCVs) have significantly reduced
disease burden caused by Streptococcus pneumoniae, a leading cause of childhood …

SUMMARY Streptococcus pneumoniae (the “pneumococcus”) is a significant human
pathogen. The key determinant of pneumococcal fitness and virulence is its ability to …

Many low-and middle-income countries have been slow to introduce the pneumococcal
conjugate vaccine (PCV) into their routine childhood immunization schedules despite a high …

Background Pneumonia remains the leading infectious cause of global childhood deaths,
despite the availability of pneumococcal conjugate vaccine (PCV) products and widespread …

Introduction Pneumococcal diseases are common and cause significant morbidity and
mortality, with higher rates especially in developing areas including many in the Asia-Pacific …

Objectives To estimate the coverage and willingness of pneumococcal vaccination and
further explore the influencing factors of vaccination willingness among people in mainland …

As a country with the high number of deaths due to pneumococcal disease, Indonesia has
not yet included pneumococcal vaccination into the routine program. This study aimed to …

An understanding of the factors associated with the COVID-19 vaccine uptake in pregnant
women is paramount to persuade women to get vaccinated against COVID-19. We …

ObjectivesCost-effectiveness analysis (CEA) is the standard framework for informing the
efficient allocation of scarce healthcare resources. The importance of considering all …

Due to a high burden of disease of pneumonia in Vietnam, the country not including the
pneumococcal conjugate vaccine (PCV) in its National Expanded Programme of …